Historical record - last NADAC effective date: 8/21/2019
Product Information
QUETIAPINE FUMARATE 25 MG TAB is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.0441 per EA under NDC 00054022025. Its NADAC has been published 301 times since Nov 28, 2013.
FDA first approved this application on Mar 27, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054022025
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/21/2019
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA090120FDA Approved
3/27/2012
TE Code
AB
On Market Since
3/27/2012
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE FUMARATE 25 MG TAB has been published 301 times since Nov 28, 2013, and over the history we have for it it has declined 60.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0441 per EA |
|---|---|
| All-time high | $0.1299 (Feb 12, 2014) |
| All-time low | $0.0413 (Nov 21, 2018) |
| Median price | $0.0759 |
| Average price | $0.0757 |
| Largest weekly change | +20.4% (Jun 19, 2019) |
| Weeks tracked | 301 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-60.5%
Last surveyed Aug 28, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 51% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Quetiapine Fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QUETIAPINE FUMARATE 25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE FUMARATE 25 MG TAB, manufactured by Hikma Pharmaceuticals USA Inc., is $0.0441 per EA (NDC 00054022025), effective Aug 28, 2019.
How has the price of QUETIAPINE FUMARATE 25 MG TAB changed over time?
Over the history we have for it, the NADAC for QUETIAPINE FUMARATE 25 MG TAB has declined 60.5%. It has been tracked across 301 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for QUETIAPINE FUMARATE 25 MG TAB?
Since Nov 28, 2013, the NADAC for QUETIAPINE FUMARATE 25 MG TAB has ranged from a low of $0.0413 (Nov 21, 2018) to a high of $0.1299 (Feb 12, 2014), with a median of $0.0759 per EA.
Are there cheaper alternatives to QUETIAPINE FUMARATE 25 MG TAB?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUETIAPINE FUMARATE 25 MG TAB, is $0.0215 per EA — about 51% below QUETIAPINE FUMARATE 25 MG TAB.
Who manufactures QUETIAPINE FUMARATE 25 MG TAB?
QUETIAPINE FUMARATE 25 MG TAB (NDC 00054022025) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.